Uncover key drivers, emerging technologies, and competitive movements shaping the dna testing market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the DNA Testing Market by the end of 2030?
The dna testing market size has experienced significant rapid growth recently. It is projected to expand from $20.04 billion in 2025 to $22.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. The historic growth of this market stemmed from advances in molecular diagnostics, infectious disease testing demand, cancer screening adoption, laboratory automation growth, and genetic research funding.
The dna testing market is anticipated to experience robust expansion over the coming years. It is projected to reach $32.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. Factors driving this growth during the forecast period include precision medicine integration, ai-based genetic interpretation, the emergence of population screening programs, the expansion of clinical genomics, and regulatory support for molecular diagnostics. Key trends identified for this period encompass the wider application of dna testing in clinical diagnostics, its increasing utilization in prenatal and newborn screening, the growing acceptance in oncology and pharmacogenomics, the integration of automated testing platforms, and the heightened demand for personalized genetic insights.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp
What Drivers Are Shaping Future Opportunities In The DNA Testing Market?
A projected expansion of the DNA testing market is anticipated, driven by the rising occurrence of genetic disorders. These disorders are health conditions stemming from DNA anomalies in individuals, resulting in physical, developmental, or functional limitations. The growing incidence of genetic disorders can be attributed to several factors: broader genetic screening programs, advancements in diagnostic methods, heightened public understanding, and the ongoing practice of marriages between close relatives in specific communities. The DNA testing market addresses this demand by facilitating timely and precise diagnoses, evaluating prognoses, customizing treatment strategies, and guiding family-planning choices informed by a person’s genetic makeup. To illustrate this, in February 2023, data from the World Health Organization (WHO) indicated that approximately 240,000 newborns worldwide died annually within their first 28 days of life due to congenital diseases. Additionally, the Centers for Disease Control and Prevention (CDC) reported that around 6,000 babies are born with Down syndrome each year in the United States, which equates to 1 in every 700 births. Consequently, the expanding occurrence of genetic disorders is fueling the expansion of the DNA testing market.
Which Segment Groups Are Influencing The DNA Testing Market?
The dna testing market covered in this report is segmented –
1) By Product Type: Equipment, Consumables, Software And Services
2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications
Subsegments:
1) By Equipment: PCR (Polymerase Chain Reaction) Machines, Sequencing Instruments, Microarray Systems, Electrophoresis Equipment
2) By Consumables: PCR Reagents, Sequencing Reagents, Hybridization Reagents, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Services, Consulting And Technical Support
Which Trends Are Guiding The Evolution Of The DNA Testing Market?
Leading companies in the DNA testing market are concentrating on developing advanced testing solutions, such as precancer detection DNA tests, to facilitate earlier diagnosis, enable timely intervention, and improve patient outcomes in cancer care. Precancer detection DNA tests are molecular diagnostic assays designed to identify early genetic or epigenetic alterations, including mutations or methylation patterns, linked to the initial stages of cancer development, allowing medical professionals to detect the disease before symptoms appear. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company focused on esophageal cancer prevention diagnostics, launched EsoGuard 2.0. This next-generation esophageal DNA test delivers enhanced assay performance and reduced costs through improved molecular techniques and higher DNA yield. Utilizing the EsoCheck Cell Collection Device, the test analyzes esophageal cell DNA via bisulfite conversion, PCR amplification, and next-generation sequencing to identify gene-specific methylation changes associated with esophageal precancer and cancer, thereby providing clinicians with a robust tool for early detection and cancer prevention.
Who Are The Top-Performing Companies In The DNA Testing Market In Recent Years?
Major companies operating in the dna testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report
Which Region Currently Holds The Largest Share Of The DNA Testing Market?
North America was the largest region in the DNA testing market in 2025. The regions covered in the dna testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized DNA Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15358&type=smp
Browse Through More Reports Similar to the Global DNA Testing Market 2026, By The Business Research Company
Genetic Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Dna Test Kits Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report
Dna Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
